Anthem Biosciences shares have risen significantly since its listing. The company reported strong June quarter results, boosting investor confidence. Capacity expansion for custom synthesis is underway. Anthem plans to increase capacity to 425 kilolitres by September 2025. Two products received approval, expanding the commercial portfolio. Revenue jumped nearly 60% in the June quarter.